Bain Capital Public Equity Management II, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management II, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$725,000
-30.0%
659,350
-12.7%
0.05%
-40.0%
Q2 2020$1,035,000
+18.6%
755,536
-1.4%
0.08%
-21.6%
Q1 2020$873,000
-48.4%
765,986
+3.3%
0.10%
-36.2%
Q4 2019$1,691,000
+888.9%
741,573
+267.0%
0.16%
+900.0%
Q3 2019$171,000
-13.2%
202,0500.0%0.02%
-11.1%
Q2 2019$197,000202,0500.02%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q3 2020.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders